Small Pharma Inc. (OTCMKTS:DMTTF) Short Interest Down 79.1% in April

Small Pharma Inc. (OTCMKTS:DMTTFGet Rating) saw a large decline in short interest in the month of April. As of April 30th, there was short interest totalling 46,500 shares, a decline of 79.1% from the April 15th total of 222,000 shares. Based on an average daily trading volume, of 34,400 shares, the short-interest ratio is currently 1.4 days.

Shares of OTCMKTS DMTTF opened at $0.14 on Friday. The business’s 50 day moving average is $0.16 and its two-hundred day moving average is $0.24. Small Pharma has a 12 month low of $0.06 and a 12 month high of $0.97.

About Small Pharma (Get Rating)

Small Pharma Inc, a clinical stage neuropharmaceutical company, engages in the IP-led development of novel treatments for depression and other mental health conditions. The company's lead product candidate is SPL026, a N,N-dimethyltryptamine (DMT) assisted therapy that is in Phase I/IIa randomized controlled clinical trial for the treatment of major depressive disorders.

Featured Stories

Receive News & Ratings for Small Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Small Pharma and related companies with MarketBeat.com's FREE daily email newsletter.